Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 5, Issue 3, 2024

Analysis of the effect of sodium valproate on neuroimmune response in patients with refractory epilepsy

Download as PDF

DOI: 10.23977/medsc.2024.050310 | Downloads: 0 | Views: 92

Author(s)

Yanyan Zhang 1, Tianqian Jia 1, Xiaojuan Li 1, Yueyan Wang 1

Affiliation(s)

1 School of Medical Engineering, Haojing College of Shaanxi University of Science & Technology, Xi'an, Shaanxi, 712000, China

Corresponding Author

Yanyan Zhang

ABSTRACT

Epilepsy belongs to a typical group of chronic nervous system diseases, which is characterized by abnormal neuronal discharge. Patients with refractory epilepsy have poor response to traditional antiepileptic drugs. It is of great significance to select an effective regimen for the treatment of patients. Sodium valproate (VPA) is widely used as a first-line AED in the treatment of epilepsy, and the application of this drug is of great significance for the treatment of patients with epilepsy. This article is divided into four aspects to describe in detail the effects of sodium valproate on neuroimmune response in patients with refractory epilepsy. Firstly, the pharmacological effect of sodium valproate is analyzed, then the research progress of sodium valproate combined with other drugs in the treatment of refractory epilepsy is discussed, the specific effect of sodium valproate on neuroimmune response in patients with refractory epilepsy is discussed, and the research situation of this topic is prospected. It is hoped that this paper can provide reference materials for the research work of relevant personnel.

KEYWORDS

Sodium valproate; Patients with refractory epilepsy; Neuroimmune response

CITE THIS PAPER

Yanyan Zhang, Tianqian Jia, Xiaojuan Li, Yueyan Wang, Analysis of the effect of sodium valproate on neuroimmune response in patients with refractory epilepsy. MEDS Clinical Medicine (2024) Vol. 5: 63-67. DOI: http://dx.doi.org/10.23977/medsc.2024.050310.

REFERENCES

[1] Wu Q. Effect of sodium valproate on the levels of nerve factors and inflammatory factors in patients with refractory epilepsy [J]. Clinical Rational Drug Use, 2023, 16 (16): 55-58.
[2] Yi Zhi, Hu Bin, Xiao Xinlong. Efficacy comparison of sodium valproate combined with levetiracetam and carbamazepine in the treatment of adult refractory epilepsy [J]. Clinical Rational Drug Use, 2023, 16 (15): 58-60.
[3] Chu C M.Efficacy of topiramate combined with sodium valproate in the treatment of refractory epilepsy and its influence on adverse reactions and seizure frequency [J]. Medical Informatics, 2022, 35 (20): 121-123.
[4] Tang Z L. Clinical observation of sodium valproate combined with lamotrigine in the treatment of adult refractory epilepsy [J]. Journal of Weifang Medical College, 2022, 44 (03): 194-196.
[5] Zhang Hui, Zheng Dong, Fang Yaxiu et al. Efficacy of lamotrigine combined with sodium valproate in the treatment of refractory epilepsy and its effect on cognitive function and peripheral blood NSE and MBP [J]. Hainan Med, 2022, 33 (07): 872-874.
[6] Nuerbia Aboulajiang, Abdoumijiti Aji. To investigate the clinical effect of lamotrigine combined with sodium valproate in the treatment of young patients with refractory epilepsy [J]. Heilongjiang Medicine, 2021, 34 (06): 1352-1353.
[7] Qiu Wenxiu, Li Chengcheng, Chen Dan, et al. Current status and influencing factors of family resilience of primary caregivers of children with intractable epilepsy [J]. Journal of Wannan Medical College, 2024, 43 (01): 76-78+82.
[8] Niu Qianqian, Dang Xiangji, Niu Guoqiang, et al. Effects of Naoxinqing on pharmacokinetics and brain tissue distribution of carbamazepine in rats with steady-state intractable epilepsy [J]. Chinese Prescription Drug, 2024, 22 (02): 45-50.
[9] Guo Yanjun, Fang Yuan, Zhang Dapeng. Application of cognitive and behavioral nursing combined with precise dynamic extended nursing in patients with intractable epilepsy in neurology department [J]. Heilongjiang Med, 2024, 48 (03): 343-345.
[10] Zhao Yan, Ling Yun. Efficacy of lacoxamide combined with sodium valproate in the treatment of refractory epilepsy. Chinese Journal of Drug Abuse Prevention and Control, 2024, 30 (01): 10-14.
[11] Zhang Baoliang. Comparison of the effect of levetiracetam and carbamazepine in the treatment of patients with refractory epilepsy. China Minkang Med, 2023, 35 (24): 160-162.
[12] Yang Shuyi, Xie Yuhai, Gong Yuchen, et al. Prediction of prognosis of stereo-electroencephalography-guided radiofrequency thermocoagulation based on brain network characteristics in patients with refractory epilepsy [J]. Chinese Journal of Biomedical Engineering, 2023, 42 (06): 651-658.
[13] Liu Zhimin, Sang Linxia, Li Wenling, et al. Effect of continuous nursing on patients with intractable epilepsy after surgical treatment and its influencing factors of recurrence [J]. Chin J Cardio-Cerebro-Pulmonary Vascular Disease, 2023, 31 (12): 134-136+140.
[14] Zhang Dong, Liang Zhen, Li Yongge. Effect of vagus nerve stimulation on the treatment of refractory epilepsy based on HMGB1/TLR4 signaling pathway [J]. Chin J Gerontology, 2023, 43 (22): 5558-5562.
[15] Kang L L, Bai Y, Niu J L, et al. Efficacy of lamotrigine combined with sodium valproate in the treatment of children with refractory epilepsy and its effect on amino acid metabolism indexes, electrophysiological indexes and quality of life [J]. Clinical Med Research & Practice, 2023, 8 (32): 77-80.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 5116
Visits: 236091

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.